The present invention relates to hydroxamic acid derivatives that are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases. Further, the compounds of the present invention have antiprotozoal properties.

 
Web www.patentalert.com

< SUBSTITUTED QUINAZOLIN-4-YLAMINE ANALOGUES

> Histone Deacetylase Inhibitors

~ 00406